Yuichiro Kai
Kami-kojimbara, 7310293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Laparoscopic repair of Morgagni hernia with extra-abdominal sutures and ileocecal resection for colon cancer: a case report.
Journal: Journal of surgical case reports
Published: October 17, 2022
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung.
Journal: Translational lung cancer research
Published: March 15, 2021
Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: December 04, 2020
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma.
Journal: The American journal of surgical pathology
Published: June 05, 2020
Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
Journal: The Annals of thoracic surgery
Published: May 24, 2020
Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report.
Journal: Journal of medical case reports
Published: April 20, 2020
Initiation gait variability is higher in the morning in elderly inpatients.
Journal: Physical therapy research
Published: December 13, 2019
Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin.
Journal: Oncology letters
Published: October 11, 2019
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
Journal: Clinical lung cancer
Published: May 25, 2019
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
Journal: Frontiers in oncology
Published: July 23, 2018
Last Updated: 09/26/2026